Safety for Home Administration of Microdose Psilocybin Use
The goal of this laboratory study is to establish whether and which microdoses of psilocybin are safe to administer at home to healthy participants. Eligible participants will be given ascending doses of psilocybin trihydrate and a single, interspersed, randomized placebo on separate days in double-blind fashion. The participants will be asked to complete questionnaires and undergo safety assessments.
- Status
- recruiting
- Phase
- Phase 1
- Institution
- Johns Hopkins University
- Principal investigator
- Sandeep M. Nayak, MD
- Start date
- 2024-12-06
- End date
- 2027-07-01
- Registry ID
- NCT06450210
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.